Eli Lilly (Japan)

559 papers and 9.3k indexed citations

About

In recent decades, authors affiliated with Eli Lilly (Japan) have published 559 papers, which have received a total of 9.3k indexed citations. Scholars at this organization have produced 123 papers in Oncology, 115 papers in Endocrinology, Diabetes and Metabolism and 112 papers in Pulmonary and Respiratory Medicine on the topics of Diabetes Treatment and Management (83 papers), Diabetes Management and Research (65 papers) and Colorectal Cancer Treatments and Studies (48 papers). Their work is cited by papers focused on Oncology (2.2k citations), Molecular Biology (1.9k citations) and Endocrinology, Diabetes and Metabolism (1.9k citations). Authors at Eli Lilly (Japan) collaborate with scholars in Japan, United States and United Kingdom and have published in prestigious journals including Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood. Some of Eli Lilly (Japan)'s most productive authors include Takeshi Imaoka, Tomonori Oura, Masakazu Takeuchi, William Montgomery, Kaname Ueda, Yoji Morisaki, Taeko Ishii, Masayo Sato, Mika Tsujimoto and Zhihong Cai.

In The Last Decade

Eli Lilly (Japan)

524 papers receiving 9.2k citations

Countries citing scholars working at Eli Lilly (Japan)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Eli Lilly (Japan). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Eli Lilly (Japan) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Lilly (Japan) more than expected).

Fields of papers published by authors at Eli Lilly (Japan)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Eli Lilly (Japan) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Eli Lilly (Japan) at the time of their publication.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2026